Published in Stat Med on January 30, 1992
Equivalence of the mediation, confounding and suppression effect. Prev Sci (2000) 13.92
Principal stratification in causal inference. Biometrics (2002) 12.34
Odds ratios for mediation analysis for a dichotomous outcome. Am J Epidemiol (2010) 6.03
Surrogate measures and consistent surrogates. Biometrics (2013) 3.59
Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int (2010) 3.36
How much of the recent decline in the incidence of myocardial infarction in British men can be explained by changes in cardiovascular risk factors? Evidence from a prospective population-based study. Circulation (2008) 3.13
Evaluating candidate principal surrogate endpoints. Biometrics (2008) 2.74
The intermediate endpoint effect in logistic and probit regression. Clin Trials (2007) 2.67
Progression-free survival as a surrogate endpoint of overall survival in patients with metastatic renal cell carcinoma. Cancer (2013) 2.61
Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model. BMC Med Res Methodol (2010) 2.46
Tuberculosis and poverty: why are the poor at greater risk in India? PLoS One (2012) 2.31
Validation of 6-minute walk distance as a surrogate end point in pulmonary arterial hypertension trials. Circulation (2012) 2.19
Anthrax vaccine-induced antibodies provide cross-species prediction of survival to aerosol challenge. Sci Transl Med (2012) 2.17
Problem-solving therapy and supportive therapy in older adults with major depression and executive dysfunction: effect on disability. Arch Gen Psychiatry (2011) 2.00
Validation of novel imaging methodologies for use as cancer clinical trial end-points. Eur J Cancer (2008) 1.73
A bayesian approach to surrogacy assessment using principal stratification in clinical trials. Biometrics (2009) 1.69
The role of race and poverty on steps to kidney transplantation in the Southeastern United States. Am J Transplant (2012) 1.66
Biomarkers in the management and treatment of men with metastatic castration-resistant prostate cancer. Eur Urol (2011) 1.64
Carotid intimal-media thickness as a surrogate for cardiovascular disease events in trials of HMG-CoA reductase inhibitors. Curr Control Trials Cardiovasc Med (2005) 1.63
Racial disparities in pediatric access to kidney transplantation: does socioeconomic status play a role? Am J Transplant (2012) 1.59
Can biomarkers identify women at increased stroke risk? The Women's Health Initiative Hormone Trials. PLoS Clin Trials (2007) 1.54
Generalized causal mediation analysis. Biometrics (2011) 1.53
Socioeconomic background in relation to stage at diagnosis, treatment and survival in women with breast cancer. Br J Cancer (2007) 1.48
Racial ethnic differences in rates and determinants of deceased donor kidney transplantation. J Am Soc Nephrol (2011) 1.48
Socioeconomic effects on breast cancer survival: proportion attributable to stage and morphology. Br J Cancer (2003) 1.40
Comparing biomarkers as principal surrogate endpoints. Biometrics (2011) 1.39
Circulating levels of soluble KIT serve as a biomarker for clinical outcome in gastrointestinal stromal tumor patients receiving sunitinib following imatinib failure. Clin Cancer Res (2009) 1.38
CDC/NIH Workshop. Tuberculosis biomarker and surrogate endpoint research roadmap. Am J Respir Crit Care Med (2011) 1.37
Screen-detected vs symptomatic breast cancer: is improved survival due to stage migration alone? Br J Cancer (2008) 1.35
Molecular characteristics of screen-detected vs symptomatic breast cancers and their impact on survival. Br J Cancer (2009) 1.23
Dampness and mold in the home and depression: an examination of mold-related illness and perceived control of one's home as possible depression pathways. Am J Public Health (2007) 1.23
Rising adiposity curbing decline in the incidence of myocardial infarction: 20-year follow-up of British men and women in the Whitehall II cohort. Eur Heart J (2011) 1.18
On assessing surrogacy in a single trial setting using a semicompeting risks paradigm. Biometrics (2009) 1.14
Effects of genital ulcer disease and herpes simplex virus type 2 on the efficacy of male circumcision for HIV prevention: Analyses from the Rakai trials. PLoS Med (2009) 1.13
Design and estimation for evaluating principal surrogate markers in vaccine trials. Biometrics (2013) 1.08
The perils of surrogate endpoints. Eur Heart J (2015) 1.03
Meta-analysis for the evaluation of surrogate endpoints in cancer clinical trials. Int J Clin Oncol (2009) 1.02
Is the recent rise in type 2 diabetes incidence from 1984 to 2007 explained by the trend in increasing BMI?: evidence from a prospective study of British men. Diabetes Care (2010) 1.00
Prostate-specific antigen changes as surrogate for overall survival in men with metastatic castration-resistant prostate cancer treated with second-line chemotherapy. J Clin Oncol (2013) 0.99
Imaging biomarker roadmap for cancer studies. Nat Rev Clin Oncol (2016) 0.99
Considerations for development of surrogate endpoints for antifracture efficacy of new treatments in osteoporosis: a perspective. J Bone Miner Res (2008) 0.98
Principal stratification and attribution prohibition: good ideas taken too far. Int J Biostat (2011) 0.98
Evaluation of progressive neuroretinal rim loss as a surrogate end point for development of visual field loss in glaucoma. Ophthalmology (2013) 0.97
Protein C: a potential biomarker in severe sepsis and a possible tool for monitoring treatment with drotrecogin alfa (activated). Crit Care (2008) 0.97
Surrogacy assessment using principal stratification when surrogate and outcome measures are multivariate normal. Biostatistics (2013) 0.95
Links between analysis of surrogate endpoints and endogeneity. Stat Med (2010) 0.94
Explaining the difference in prognosis between screen-detected and symptomatic breast cancers. Br J Cancer (2011) 0.93
Early change in proteinuria as a surrogate end point for kidney disease progression: an individual patient meta-analysis. Am J Kidney Dis (2014) 0.92
Evaluation of surrogate endpoints in randomized experiments with mixed discrete and continuous outcomes. Stat Med (2001) 0.91
Prospective relations between growth in drinking and familial stressors across adolescence. J Abnorm Psychol (2009) 0.91
Using cure models and multiple imputation to utilize recurrence as an auxiliary variable for overall survival. Clin Trials (2011) 0.90
Racial differences in determinants of live donor kidney transplantation in the United States. Am J Transplant (2013) 0.90
Causal assessment of surrogacy in a meta-analysis of colorectal cancer trials. Biostatistics (2011) 0.89
Chemoprevention of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest (2013) 0.88
Correlates of protection for rotavirus vaccines: Possible alternative trial endpoints, opportunities, and challenges. Hum Vaccin Immunother (2014) 0.87
Predicting treatment effect from surrogate endpoints and historical trials: an extrapolation involving probabilities of a binary outcome or survival to a specific time. Biometrics (2011) 0.87
Factors associated with survival in a large series of patients with malignant pleural mesothelioma in New South Wales. Br J Cancer (2014) 0.87
Surrogate endpoint analysis: an exercise in extrapolation. J Natl Cancer Inst (2012) 0.86
Surrogate endpoints in liver surgery related trials: a systematic review of the literature. HPB (Oxford) (2012) 0.86
Predicting treatment effects using biomarker data in a meta-analysis of clinical trials. Stat Med (2010) 0.85
A unified procedure for meta-analytic evaluation of surrogate end points in randomized clinical trials. Biostatistics (2012) 0.84
Do research activities during college, medical school, and residency mediate racial/ethnic disparities in full-time faculty appointments at U.S. Medical schools? Acad Med (2012) 0.84
When is the difference method conservative for assessing mediation? Am J Epidemiol (2015) 0.83
Are hemodynamics surrogate end points in pulmonary arterial hypertension? Circulation (2014) 0.83
Local geographic variation in chronic liver disease and hepatocellular carcinoma: contributions of socioeconomic deprivation, alcohol retail outlets, and lifestyle. Ann Epidemiol (2013) 0.83
Surrogacy assessment using principal stratification and a Gaussian copula model. Stat Methods Med Res (2014) 0.83
Evaluating the Proportion of Treatment Effect Explained by a Continuous Surrogate Marker in Logistic or Probit Regression Models. Stat Biopharm Res (2010) 0.82
Meta-analysis of the association between progression-free survival and overall survival in metastatic colorectal cancer. Int J Colorectal Dis (2011) 0.81
Progression-free survival as a primary endpoint in clinical trials of metastatic colorectal cancer. Curr Oncol (2011) 0.81
Copy number imbalances between screen- and symptom-detected breast cancers and impact on disease-free survival. Cancer Prev Res (Phila) (2011) 0.81
Familial tendency and risk of nasopharyngeal carcinoma in taiwan: effects of covariates on risk. Am J Epidemiol (2010) 0.81
The association of coffee intake with liver cancer risk is mediated by biomarkers of inflammation and hepatocellular injury: data from the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr (2015) 0.81
Study design issues in evaluating immune biomarkers. Curr Opin HIV AIDS (2013) 0.80
Surrogate markers for time-varying treatments and outcomes. Clin Trials (2015) 0.80
Protein C as a surrogate end-point for clinical trials of sepsis. Crit Care (2008) 0.79
Exposure to Maternal Diabetes in Utero and DNA Methylation Patterns in the Offspring. Immunometabolism (2013) 0.79
Statistical controversies in clinical research: an initial evaluation of a surrogate end point using a single randomized clinical trial and the Prentice criteria. Ann Oncol (2015) 0.79
Oral contraceptive pill use is associated with reduced odds of nonalcoholic fatty liver disease in menstruating women: results from NHANES III. J Gastroenterol (2012) 0.79
Translating neoadjuvant therapy into survival benefits: one size does not fit all. Nat Rev Clin Oncol (2016) 0.78
Strength of Validation for Surrogate End Points Used in the US Food and Drug Administration's Approval of Oncology Drugs. Mayo Clin Proc (2016) 0.78
Robust estimation of the proportion of treatment effect explained by surrogate marker information. Stat Med (2015) 0.77
Biomarkers and surrogate endpoints in kidney disease. Pediatr Nephrol (2015) 0.77
Ursodeoxycholic acid improves bilirubin but not albumin in primary biliary cirrhosis: further evidence for nonefficacy. Biomed Res Int (2013) 0.77
Developing retinal biomarkers of neurological disease: an analytical perspective. Biomark Med (2015) 0.76
Breast density and mode of detection in relation to breast cancer specific survival: a cohort study. BMC Cancer (2014) 0.76
Short-Term Relapse Quantitation as a Fully Surrogate Endpoint for Long-Term Sustained Progression of Disability in RRMS Patients Treated with Natalizumab. Neurol Res Int (2011) 0.76
Sunburn, sun exposure, and sun sensitivity in the Study of Nevi in Children. Ann Epidemiol (2015) 0.76
Influences of age, sex, and LDL-C change on cardiovascular risk reduction with pravastatin treatment in elderly Japanese patients: A post hoc analysis of data from the Pravastatin Anti-atherosclerosis Trial in the Elderly (PATE). Curr Ther Res Clin Exp (2006) 0.75
A Bayesian prediction model between a biomarker and the clinical endpoint for dichotomous variables. Trials (2014) 0.75
Evaluating surrogate marker information using censored data. Stat Med (2017) 0.75
SOFA and mortality endpoints in randomized controlled trials: a systematic review and meta-regression analysis. Crit Care (2017) 0.75
Accommodating missingness when assessing surrogacy via principal stratification. Clin Trials (2013) 0.75
Flexible stopping boundaries when changing primary endpoints after unblinded interim analyses. J Biopharm Stat (2014) 0.75
A causal framework for surrogate endpoints with semi-competing risks data. Stat Probab Lett (2012) 0.75
Mediation analysis of gestational age, congenital heart defects, and infant birth-weight. BMC Res Notes (2014) 0.75
Beyond Correlations, Sensitivities, and Specificities: A Roadmap for Demonstrating Utility of Advanced Imaging in Oncology Treatment and Clinical Trial Design. Acad Radiol (2017) 0.75
Links between causal effects and causal association for surrogacy evaluation in a gaussian setting. Stat Med (2017) 0.75
Mediators of Racial/Ethnic Disparities in Mentored K Award Receipt Among U.S. Medical School Graduates. Acad Med (2017) 0.75
Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. Am J Epidemiol (1997) 9.25
Sample size for studying intermediate endpoints within intervention trails or observational studies. Am J Epidemiol (1992) 6.92
Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst (2003) 6.20
Epidemiologic studies utilizing surveys: accounting for the sampling design. Am J Public Health (1991) 4.89
Bone mass and the risk of breast cancer among postmenopausal women. N Engl J Med (1997) 3.96
Birth weight among women of different ethnic groups. JAMA (1986) 3.47
Evaluation of alternative approaches to assign nutrient values to food groups in food frequency questionnaires. Am J Epidemiol (2000) 3.46
Smoking duration, intensity, and risk of Parkinson disease. Neurology (2010) 3.19
Index-based dietary patterns and risk of colorectal cancer: the NIH-AARP Diet and Health Study. Am J Epidemiol (2008) 3.16
Effects of alcohol consumption on plasma and urinary hormone concentrations in premenopausal women. J Natl Cancer Inst (1993) 2.59
A prospective study of diet quality and mortality in women. JAMA (2000) 2.52
Empirical evidence of correlated biases in dietary assessment instruments and its implications. Am J Epidemiol (2001) 2.33
Adult stature and risk of cancer. Cancer Res (1988) 2.26
Low energy reporters vs others: a comparison of reported food intakes. Eur J Clin Nutr (2000) 2.23
A prospective study of the development of breast cancer in 16,692 women with benign breast disease. Am J Epidemiol (1988) 2.20
Moderate caffeine use and the risk of spontaneous abortion and intrauterine growth retardation. JAMA (1993) 2.20
Evaluation of 2 brief instruments and a food-frequency questionnaire to estimate daily number of servings of fruit and vegetables. Am J Clin Nutr (2000) 2.19
Sudden death: lessons from subsets in population studies. J Am Coll Cardiol (1985) 2.11
Dietary diversity and subsequent mortality in the First National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Am J Clin Nutr (1993) 2.09
Energy density of diets reported by American adults: association with food group intake, nutrient intake, and body weight. Int J Obes (Lond) (2005) 2.00
Test reliability is critically important to molecular epidemiology: an example from studies of human papillomavirus infection and cervical neoplasia. Cancer Res (1994) 1.89
Alcohol consumption and breast cancer in the epidemiologic follow-up study of the first National Health and Nutrition Examination Survey. N Engl J Med (1987) 1.87
Dietary diversity and subsequent cause-specific mortality in the NHANES I epidemiologic follow-up study. J Am Coll Nutr (1995) 1.86
Recent trends in coronary risk factors in the USSR. Am J Public Health (1982) 1.84
Infant feeding and childhood cancer. Lancet (1988) 1.80
Is colonoscopy needed for the nonadvanced adenoma found on sigmoidoscopy? The Polyp Prevention Trial. Gastroenterology (1998) 1.78
Parental age at child's birth and son's risk of prostate cancer. The Framingham Study. Am J Epidemiol (1999) 1.77
The association between health care coverage and the use of cancer screening tests. Results from the 1992 National Health Interview Survey. Med Care (1998) 1.71
Improving food frequency questionnaires: a qualitative approach using cognitive interviewing. J Am Diet Assoc (1995) 1.68
Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk. Cancer Epidemiol Biomarkers Prev (1996) 1.67
The impact of dietary measurement error on planning sample size required in a cohort study. Am J Epidemiol (1990) 1.66
Small-sample adjustments for Wald-type tests using sandwich estimators. Biometrics (2001) 1.64
Hormone replacement therapy and colorectal adenoma recurrence among women in the Polyp Prevention Trial. J Natl Cancer Inst (2001) 1.62
Racism, society, and disease: an exploration of the social and biological mechanisms of differential mortality. Int J Health Serv (1981) 1.62
Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysis. Br J Cancer (2009) 1.61
Body fat distribution and breast cancer in the Framingham Study. J Natl Cancer Inst (1990) 1.60
Choice of column scores for testing independence in ordered 2 X K contingency tables. Biometrics (1987) 1.59
Maternal alcohol consumption and birth weight. How much drinking during pregnancy is safe? JAMA (1984) 1.58
The fluctuation of plasma carotenoid concentrations by phase of the menstrual cycle: a controlled diet study. Am J Clin Nutr (1996) 1.57
Serum cholesterol and cancer in the NHANES I epidemiologic followup study. National Health and Nutrition Examination Survey. Lancet (1987) 1.57
Can energy adjustment separate the effects of energy from those of specific macronutrients? Am J Epidemiol (1994) 1.56
Improved mortality among U.S. Blacks, 1968-1978: the role of antiracist struggle. Int J Health Serv (1981) 1.53
Risk of neural tube defects in relation to maternal fertility and fertility drug use. Lancet (1990) 1.49
Implementation of a 4-y, high-fiber, high-fruit-and-vegetable, low-fat dietary intervention: results of dietary changes in the Polyp Prevention Trial. Am J Clin Nutr (2001) 1.46
Male pattern baldness and clinical prostate cancer in the epidemiologic follow-up of the first National Health and Nutrition Examination Survey. Cancer Epidemiol Biomarkers Prev (2000) 1.46
Precision of the doubly labeled water method in a large-scale application: evaluation of a streamlined-dosing protocol in the Observing Protein and Energy Nutrition (OPEN) study. Eur J Clin Nutr (2003) 1.46
Temporal trends in the socioeconomic gradient for breast cancer mortality among US women. Am J Public Health (1994) 1.45
Multiple testing of hypotheses in comparing two groups. Ann Intern Med (1984) 1.44
Physical activities and future risk of Parkinson disease. Neurology (2010) 1.42
The Pima infant feeding study: breastfeeding and respiratory infections during the first year of life. Int J Epidemiol (1984) 1.36
Health problems reported by residents of a neighborhood contaminated by a hazardous waste facility. Am J Ind Med (1987) 1.35
Prospective study of relative weight and risk of breast cancer: the Breast Cancer Detection Demonstration Project follow-up study, 1979 to 1987-1989. Am J Epidemiol (1996) 1.34
Dietary patterns associated with a low-fat diet in the national health examination follow-up study: identification of potential confounders for epidemiologic analyses. Am J Epidemiol (1993) 1.32
Anemia and spontaneous preterm birth. Am J Obstet Gynecol (1991) 1.32
Low birth weight across generations. JAMA (1984) 1.32
Physical activity, sedentary behaviours, and the prevention of endometrial cancer. Br J Cancer (2010) 1.31
A prospective study of menopausal hormones and risk of colorectal cancer (United States) Cancer Causes Control (1997) 1.30
The pattern of mass disease in the U.S.S.R.: a product of socialist or capitalist development? Int J Health Serv (1982) 1.30
Relationships of age and reproductive characteristics with plasma estrogens and androgens in premenopausal women. Cancer Epidemiol Biomarkers Prev (1995) 1.28
Relation of arsenic exposure to lung cancer among tin miners in Yunnan Province, China. Br J Ind Med (1989) 1.26
Intake of vitamins E, C, and A and risk of lung cancer. The NHANES I epidemiologic followup study. First National Health and Nutrition Examination Survey. Am J Epidemiol (1997) 1.26
Diet and lung cancer mortality: a 1987 National Health Interview Survey cohort study. Cancer Causes Control (2000) 1.25
Past body mass index and risk of mortality among women. Int J Obes (Lond) (2008) 1.25
The polyp prevention trial II: dietary intervention program and participant baseline dietary characteristics. Cancer Epidemiol Biomarkers Prev (1996) 1.23
Tea, coffee, carbonated soft drinks and upper gastrointestinal tract cancer risk in a large United States prospective cohort study. Eur J Cancer (2010) 1.22
Risk factors for breast cancer in black women. J Natl Cancer Inst (1987) 1.22
Comparing new and old screening tests when a reference procedure cannot be performed on all screenees. Example of automated cytometry for early detection of cervical cancer. Am J Epidemiol (1987) 1.21
Associations between food patterns defined by cluster analysis and colorectal cancer incidence in the NIH-AARP diet and health study. Eur J Clin Nutr (2008) 1.20
A longitudinal study of infant feeding and obesity throughout life course. Int J Obes (Lond) (2007) 1.19
Socioeconomic status and breast cancer mortality, 1989 through 1993: an analysis of education data from death certificates. Am J Public Health (1997) 1.16
Quantitative evaluation of the radon and lung cancer association in a case control study of Chinese tin miners. Cancer Res (1990) 1.16
Moderate elevation of body iron level and increased risk of cancer occurrence and death. Int J Cancer (1994) 1.15
Frequency of eating occasions and weight change in the NHANES I Epidemiologic Follow-up Study. Int J Obes Relat Metab Disord (1995) 1.15
Dietary diversity in the US population, NHANES II, 1976-1980. J Am Diet Assoc (1991) 1.14
Interplay between design and analysis for behavioral intervention trials with community as the unit of randomization. Am J Epidemiol (1995) 1.13
Alcohol and head and neck cancer risk in a prospective study. Br J Cancer (2007) 1.13
Effect of age, parity, and smoking on pregnancy outcome: a population-based study. Am J Obstet Gynecol (1993) 1.12
Breast cancer risk assessed by anthropometry in the NHANES I epidemiological follow-up study. Cancer Res (1988) 1.12
Food group intake patterns and associated nutrient profiles of the US population. J Am Diet Assoc (1991) 1.07
Effects of dietary fat and fiber on plasma and urine androgens and estrogens in men: a controlled feeding study. Am J Clin Nutr (1996) 1.05
Intake of meat, meat mutagens, and iron and the risk of breast cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Br J Cancer (2009) 1.05
Prevalence of family history of breast, colorectal, prostate, and lung cancer in a population-based study. Public Health Genomics (2010) 1.05
Dietary fat and breast cancer in the National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. J Natl Cancer Inst (1987) 1.04
Alcohol intake and risk of thyroid cancer in the NIH-AARP Diet and Health Study. Br J Cancer (2009) 1.04
Predictors of vitamin D biochemical status in a large sample of middle-aged male smokers in Finland. Eur J Clin Nutr (2010) 1.04
An epidemiological perspective of sudden death. 26-year follow-up in the Framingham Study. Drugs (1984) 1.02
Risk of renal cell carcinoma in relation to blood telomere length in a population-based case-control study. Br J Cancer (2011) 1.02
Association of change in body mass with breast cancer. Cancer Res (1990) 1.02
Bone mass and the risk of colon cancer among postmenopausal women: the Framingham study. Am J Epidemiol (2001) 1.02
Physical activity and risk of large bowel cancer in the Framingham Study. Cancer Res (1990) 1.00
Sudden death in the Framingham Heart Study. Differences in incidence and risk factors by sex and coronary disease status. Am J Epidemiol (1984) 1.00
Cesarean section and subsequent fertility: results from the 1982 National Survey of Family Growth. Fertil Steril (1985) 1.00
Evening eating and its relation to self-reported body weight and nutrient intake in women, CSFII 1985-86. J Am Coll Nutr (1995) 1.00
The relation of reported alcohol ingestion to plasma levels of estrogens and androgens in premenopausal women (Maryland, United States). Cancer Causes Control (1994) 1.00
Evening eating and subsequent long-term weight change in a national cohort. Int J Obes Relat Metab Disord (1997) 1.00
Maternal substance use during pregnancy and developmental outcome at age three. J Subst Abuse (2000) 0.99
Energy adjustment methods for nutritional epidemiology: the effect of categorization. Am J Epidemiol (1994) 0.99